510 related articles for article (PubMed ID: 3541449)
21. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
[No Abstract] [Full Text] [Related]
22. [Clinical significance of the hepatitis Delta virus and its incidence in virus B positive chronic liver diseases].
Horváth G; Tolvaj G; Dávid K
Orv Hetil; 1992 Jul; 133 Suppl 1():39-44. PubMed ID: 1630804
[TBL] [Abstract][Full Text] [Related]
23. Chronic delta hepatitis: a difficult problem for the hepatologist.
Picciotto A; Celle G
Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
[TBL] [Abstract][Full Text] [Related]
24. A possible misdiagnosis in patients presenting with acute HBsAg-negative hepatitis: the role of hepatitis delta virus.
Caredda F; Antinori S; Pastecchia C; Coppin P; Arici C; Fracassetti O
Infection; 1988; 16(6):358-9. PubMed ID: 3220581
[TBL] [Abstract][Full Text] [Related]
25. Suppression of hepatitis delta virus by concurrent hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.
Liaw YF; Hsieh SY; Chien RN; Chen TJ; Sheen IS; Chu CM
Prog Clin Biol Res; 1993; 382():229-34. PubMed ID: 8502686
[No Abstract] [Full Text] [Related]
26. Delta hepatitis in Malaysia.
Sinniah M; Dimitrakakis M; Tan DS
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of wildtype and pre-C HBV variants in HBsAg/anti-HBe positive carriers with chronic hepatitis delta virus infection.
Santantonio T; Jung MC; Monno L; Milella M; Iacovazzi T; Pastore G; Will H
Prog Clin Biol Res; 1993; 382():235-42. PubMed ID: 8502687
[No Abstract] [Full Text] [Related]
28. Hepatitis delta virus superinfection in Guangzhou area.
Chen GH; Zhang MD; Huang W
Chin Med J (Engl); 1990 Jun; 103(6):451-4. PubMed ID: 2119957
[TBL] [Abstract][Full Text] [Related]
29. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
30. Experimental transmission of the delta virus to a hepatitis B chronic carrier chimpanzee with the development of persistent delta carriage.
Fields HA; Govindarajan S; Margolis HS; Schable CD; Ebert JW; Maynard JE
Am J Pathol; 1986 Feb; 122(2):308-14. PubMed ID: 3511725
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B and D virus infection among drug abusers in Taiwan.
Lee SD; Wang JY; Wu JC; Chiang YT; Tsai YT; Lo KJ
J Med Virol; 1986 Nov; 20(3):247-52. PubMed ID: 3783132
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus clearance from serum and liver after acute hepatitis delta virus superinfection in chronic HBsAg carriers.
Pastore G; Monno L; Santantonio T; Angarano G; Milella M; Giannelli A; Fiore JR
J Med Virol; 1990 Aug; 31(4):284-90. PubMed ID: 2269880
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cell function during interferon treatment of delta hepatitis.
Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
[No Abstract] [Full Text] [Related]
34. Detection of IgM antibodies to delta antigen after coinfection and superinfection with the delta virus.
Dimitrakakis M; Waters MJ; Wootton A; Gust I
J Med Virol; 1986 Dec; 20(4):305-11. PubMed ID: 3794670
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.
el Zayadi A; Ponzetto A; Selim O; Forzani B; Lavarini C; Rizzetto M
Hepatogastroenterology; 1988 Dec; 35(6):313-5. PubMed ID: 3265126
[TBL] [Abstract][Full Text] [Related]
36. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
Picciotto L; Abrescia N; Ciampi R
Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
[TBL] [Abstract][Full Text] [Related]
37. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
Calzia R; Ciravegna B; Navone C; Tolentino P
Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
[TBL] [Abstract][Full Text] [Related]
38. Clinical features of hepatitis delta virus infection in a northern Italian area.
Pasetti G; Calzetti C; Degli Antoni A; Ferrari C; Penna A; Fiaccadori F
Infection; 1988; 16(6):345-8. PubMed ID: 3220579
[TBL] [Abstract][Full Text] [Related]
39. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers.
Hadziyannis SJ; Sherman M; Lieberman HM; Shafritz DA
Hepatology; 1985; 5(4):544-7. PubMed ID: 4018727
[TBL] [Abstract][Full Text] [Related]
40. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
